Comparison of the protective effects of cromolyn sodium and nedocromil sodium in the treatment of exercise-induced asthma in children
View abstract on PubMed
Summary
This summary is machine-generated.Nedocromil sodium and cromolyn sodium equally prevent exercise-induced asthma in children. Both medications outperformed placebo in this double-blind study, offering significant protection against asthma triggers.
Area Of Science
- Pediatric Pulmonology
- Allergy and Immunology
- Pharmacology
Background
- Exercise-induced asthma (EIA) is a common condition in children, impacting their quality of life.
- Current treatments aim to prevent EIA symptoms triggered by physical activity.
Purpose Of The Study
- To compare the efficacy of nedocromil sodium with cromolyn sodium in preventing EIA in pediatric patients.
- To evaluate the effectiveness of these medications against a placebo.
Main Methods
- A double-blind, crossover, placebo-controlled study was conducted.
- Seventeen children with asthma participated, receiving metered-dose inhaler treatments.
- Medications included cromolyn sodium (10 mg), nedocromil sodium (4 mg), and placebo.
Main Results
- Both nedocromil sodium and cromolyn sodium demonstrated significant protection against EIA.
- The protective effects of nedocromil sodium and cromolyn sodium were comparable.
- Both active treatments were superior to placebo in preventing exercise-induced asthma.
Conclusions
- Nedocromil sodium and cromolyn sodium offer equivalent protection against EIA in children.
- Pressurized aerosol administration of these medications is effective for EIA prevention.